Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

No evidence for depression screening in cardiovascular care settings: a comment on CANMAT task force recommendations.

Thombs BD.

Ann Clin Psychiatry. 2012 Nov;24(4):319-20; author reply 320-2. No abstract available.

PMID:
23145390
2.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions.

Ramasubbu R, Taylor VH, Samaan Z, Sockalingham S, Li M, Patten S, Rodin G, Schaffer A, Beaulieu S, McIntyre RS; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):91-109. Review.

PMID:
22303525
3.

The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles.

Ramasubbu R, Beaulieu S, Taylor VH, Schaffer A, McIntyre RS; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):82-90. Review.

PMID:
22303524
4.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Sch├╝tz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
5.

The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.

Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, Swinson R, Yatham LN; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):6-22. Review.

PMID:
22303519
6.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.

Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):23-37. Review.

PMID:
22303520
7.
8.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.

McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):69-81. Review.

PMID:
22303523
9.

Comment on: 'antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence'.

Ban TA.

Int J Neuropsychopharmacol. 2008 Jun;11(4):583-5; author reply 587-9. doi: 10.1017/S1461145708008729. Epub 2008 Apr 18. No abstract available.

PMID:
18419850
10.

Screening for depression in primary care: recommendation statement from the Canadian Task Force on Preventive Health Care.

MacMillan HL, Patterson CJ, Wathen CN, Feightner JW, Bessette P, Elford RW, Feig DS, Langley J, Palda VA, Patterson C, Reeder BA, Walton R; Canadian Task Force on Preventive Health Care.

CMAJ. 2005 Jan 4;172(1):33-5. No abstract available.

11.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders.

Rosenbluth M, Macqueen G, McIntyre RS, Beaulieu S, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):56-68. Review.

PMID:
22303522
13.

Depression in primary care: quality improvement and economics.

Frank RG.

Manag Care. 2008 Mar;17(3 Suppl 2):22-4; discussion 25-6. No abstract available.

14.

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.

Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB; Canadian Network for Mood and Anxiety Treatments (CANMAT).

J Affect Disord. 2009 Oct;117 Suppl 1:S15-25. doi: 10.1016/j.jad.2009.06.042. Epub 2009 Aug 13.

PMID:
19682749
15.

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV; Canadian Network for Mood and Anxiety Treatments (CANMAT).

J Affect Disord. 2009 Oct;117 Suppl 1:S26-43. doi: 10.1016/j.jad.2009.06.041. Epub 2009 Aug 11.

PMID:
19674794
16.

The rise and fall of mood stabilizers.

Malhi GS, Goodwin GM.

Aust N Z J Psychiatry. 2007 Oct;41(10):779-83. No abstract available.

PMID:
17828650
17.

Structural models of comorbidity among common mental disorders: connections to chronic pain.

Krueger RF, Tackett JL, Markon KE.

Adv Psychosom Med. 2004;25:63-77. Review.

PMID:
15248367
18.

Mood disorders: an overview--Part III.

[No authors listed]

Harv Ment Health Lett. 1998 Feb;14(8):1-5. No abstract available.

PMID:
15344234
19.

Do antidepressant and antianxiety drugs increase chronicity in affective disorders?

Fava GA.

Psychother Psychosom. 1994;61(3-4):125-31. Review. No abstract available.

PMID:
7915039
20.

Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial.

Horn EK, van Benthem TB, Hakkaart-van Roijen L, van Marwijk HW, Beekman AT, Rutten FF, van der Feltz-Cornelis CM.

BMC Health Serv Res. 2007 Feb 26;7:28.

Items per page

Supplemental Content

Write to the Help Desk